Actavis to buy Allergan in $66 billion deal

Deal will thwart a hostile takeover bid from Valeant Pharmaceuticals and Bill Ackman.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.